Rush Alzheimer's Disease Cntr.

1750 West Harrison Street
Chicago, Illinois 60612

We've found

2 trials

at this facility

A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Chicago, IL

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!